» Articles » PMID: 36846784

Identification of a Prototype Human Gut Subsp. Strain Based on Comparative and Functional Genomic Approaches

Abstract

Bifidobacteria are extensively exploited for the formulation of probiotic food supplements due to their claimed ability to exert health-beneficial effects upon their host. However, most commercialized probiotics are tested and selected for their safety features rather than for their effective abilities to interact with the host and/or other intestinal microbial players. In this study, we applied an ecological and phylogenomic-driven selection to identify novel subsp. strains with a presumed high fitness in the human gut. Such analyses allowed the identification of a prototype microorganism to investigate the genetic traits encompassed by the autochthonous bifidobacterial human gut communities. subsp. PRL2022 was selected due to its close genomic relationship with the calculated model representative of the adult human-gut associated subsp. taxon. The interactomic features of PRL2022 with the human host as well as with key representative intestinal microbial members were assayed using models, revealing how this bifidobacterial gut strain is able to establish extensive cross-talk with both the host and other microbial residents of the human intestine.

Citing Articles

Molecular cross-talk among human intestinal bifidobacteria as explored by a human gut model.

Rizzo S, Alessandri G, Tarracchini C, Bianchi M, Viappiani A, Mancabelli L Front Microbiol. 2024; 15:1435960.

PMID: 39314876 PMC: 11418510. DOI: 10.3389/fmicb.2024.1435960.


Characterization of a subsp. reference strain based on ecology and transcriptomics.

Lugli G, Argentini C, Tarracchini C, Mancabelli L, Viappiani A, Anzalone R Appl Environ Microbiol. 2024; 90(10):e0108024.

PMID: 39235395 PMC: 11497779. DOI: 10.1128/aem.01080-24.


Genomic and ecological approaches to identify the prototype of the healthy human gut microbiota.

Argentini C, Lugli G, Tarracchini C, Fontana F, Mancabelli L, Viappiani A Front Microbiol. 2024; 15:1349391.

PMID: 38426063 PMC: 10902438. DOI: 10.3389/fmicb.2024.1349391.


Ecology- and genome-based identification of the prototype of the healthy human gut microbiota.

Argentini C, Lugli G, Tarracchini C, Fontana F, Mancabelli L, Viappiani A Appl Environ Microbiol. 2024; 90(2):e0201423.

PMID: 38294252 PMC: 10880601. DOI: 10.1128/aem.02014-23.


Amorphous silica nanoparticles and the human gut microbiota: a relationship with multiple implications.

Bianchi M, Chiu M, Taurino G, Bergamaschi E, Turroni F, Mancabelli L J Nanobiotechnology. 2024; 22(1):45.

PMID: 38291460 PMC: 10826219. DOI: 10.1186/s12951-024-02305-x.


References
1.
Zhao Y, Wu J, Yang J, Sun S, Xiao J, Yu J . PGAP: pan-genomes analysis pipeline. Bioinformatics. 2011; 28(3):416-8. PMC: 3268234. DOI: 10.1093/bioinformatics/btr655. View

2.
Costea P, Hildebrand F, Arumugam M, Backhed F, Blaser M, Bushman F . Enterotypes in the landscape of gut microbial community composition. Nat Microbiol. 2017; 3(1):8-16. PMC: 5832044. DOI: 10.1038/s41564-017-0072-8. View

3.
Webster S, Wong G, OToole G . The Power of Touch: Type 4 Pili, the von Willebrand A Domain, and Surface Sensing by Pseudomonas aeruginosa. J Bacteriol. 2022; 204(6):e0008422. PMC: 9210963. DOI: 10.1128/jb.00084-22. View

4.
Sun Z, He X, Brancaccio V, Yuan J, Riedel C . Bifidobacteria exhibit LuxS-dependent autoinducer 2 activity and biofilm formation. PLoS One. 2014; 9(2):e88260. PMC: 3914940. DOI: 10.1371/journal.pone.0088260. View

5.
Schiavi E, Plattner S, Rodriguez-Perez N, Barcik W, Frei R, Ferstl R . Exopolysaccharide from Bifidobacterium longum subsp. longum 35624™ modulates murine allergic airway responses. Benef Microbes. 2018; 9(5):761-773. DOI: 10.3920/BM2017.0180. View